BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Inogen, Inc. (“Inogen” or the “Company”) (NASDAQ:INGN) concerning possible violations of federal securities laws. Inogen is a medical technology company that develops, manufactures and markets portable oxygen concentrators.
The investigation is related to certain statements issued by the Company concerning Inogen’s operations and financial performance. On March 11, 2015, the Company announced that during the first quarter of 2015 certain potential accounting matters were discovered by management, which prompted the Audit Committee, with the assistance of independent advisors, to commence an internal investigation. According to a Company press release, “the Audit Committee is investigating whether there were any violations of the Company's accounting policies associated with these potential accounting matters.” Following this news, Inogen shares declined as much as $4.37 per share, or nearly 12% below the previous closing price, in intraday trading on March 12, 2015.
If you purchased Inogen shares, if you have information or would like to learn more about these claims, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.